Early loss of dopaminergic terminals in striosomes after MDMA administration to mice

Synapse

Volumn 62, Issue 1, 2008, Pages 80-84

  Granado, Noelia ^a,b   Escobedo, Isabel ^c   O'Shea, Esther ^c   Colado, Ma Isabel ^c   Moratalla, Rosario ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Addiction; Dopamine; Ecstasy; Neurotoxicity; Striatum; TH

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE; DOPAMINE TRANSPORTER; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

ADDICTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ENZYME LOCALIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONG TERM EXPOSURE; MALE; MATRIX COMPARTMENT; MOUSE; NERVE CELL DEGENERATION; NERVE ENDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; STRIOSOME;

ANIMALS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HALLUCINOGENS; IMMUNOHISTOCHEMISTRY; MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PRESYNAPTIC TERMINALS; TYROSINE 3-MONOOXYGENASE;

EID: 36348951506     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20466     Document Type: Article

References (25)

1. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, Elde R. 1995. Distribution and targeting of a mu-opioid receptor (MORI) in brain and spinal cord. J Neurosci 15:3328-3341.
2. Berretta S, Parthasarathy HB, Graybiel AM. 1997. Local release of gabaergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J Neurosci 17:4752-4763.
3. Broening HW, Morford LL, Vorhees CV. 2005. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 56:84-93.
4. Burke RE, Baimbridge KG. 1993. Relative loss of the striatal striosome compartment, defined by calbindin-d28k immunostaining, following developmental hypoxic-ischemic injury. Neuroscience 56:305-315.
5. Cadet JL, Ladenheim B, Hirata H, Rothman RB, Ali S, Carlson E, Epstein C, Moran TH. 1995. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn-superoxide dismutase transgenic mice. Synapse 21:169-176.
6. Camarero J, Sanchez V, O'Shea E, Green AR, Colado MI. 2002. Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 On 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81:961-972.
7. Figueredo-Cardenas G, Harris CL, Anderson KD, Reiner A. 1998. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types. Exp Neurol 149:356-372.
8. Fiskum G, Murphy AN, Beal MF 1999. Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab 19:351-369.
9. Fornai F, Lenzi P, Frenzilli G, Gesi M, Ferrucci M, Lazzeri G, Biagioni F, Nigro M, Falleni A, Giusiani M, Pellegrini A, Blandini F, Ruggieri S, Paparelli A. 2004. DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following mdma (ecstasy). Psychopharmacology (Berl) 173:353-363.
10. Granado N, Ortiz O, Suarez LM, Martin ED, Cena V, Solis JM, Moratalla R. 2007.D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-induced Arc and Zif268 expression in the hippocampus. Cereb Cortex 2007, March 29; (Epub ahead of print).
11. Grande C, Zhu H, Martin AB, Lee M, Ortiz O, Hiroi N, Moratalla R. 2004. Chronic treatment with atypical neuroleptics induces striosomal FosB/Deltafosb expression in rats. Biol Psychiatry 55:457-163.
12. Graybiel AM. 1990. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
13. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI. 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508.
14. Hedreen JC, Folstein SE. 1995. Early loss of neostriatal striosome neurons in Huntington's disease. J Neuropathol Exp Neurol 54:105-120.
15. Iravani MM, Syed E, Jackson MJ, Johnston LC, Smith LA, Jenner P. 2005. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 21:841-854.
16. Medina L, Figueredo-Cardenas G, Rothstein JD, Reiner A. 1996. Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups. Exp Neurol 142:287-295.
17. Mills EM, Banks ML, Sprague JE, Finkel T. 2003. Pharmacology: uncoupling the agony from ecstasy. Nature 426:403-404.
18. Moratalla R, Elibol B, Vallejo M, Graybiel AM. 1996. Network-level changes in expression of inducible fos-jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17:147-156.
19. Moratalla R, Quinn B, Delanney LE, Irwin I, Langston JW, Graybiel AM. 1992. Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine. Proc Natl Acad Sci USA 89:3859-3863.
20. O'Shea E, Esteban B, Camarero J, Green AR, Colado MI. 2001. Effect Of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology 40:65-74.
21. Pavon N, Martin AB, Mendialdua A, Moratalla R. 2006. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 59:64-74.
22. Rivera A, Alberti I, Martin AB, Narvaez JA, De La CA, Moratalla R. 2002. Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype. Eur J Neurosci 16:2049-2058.
23. Vorhees CV, Schaefer TL, Williams MT. 2007. Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: Effects of dose distribution. Synapse 61:488-499.
24. White NM, Hiroi N. 1998. Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc Natl Acad Sci USA 95:6486-6491.
25. Zhang P, Anglade P, Hirsch EC, Javoy-Agid F, Agid Y. 1994. Distribution of manganese-dependent superoxide dismutase in the human brain. Neuroscience 61:317-330.